Number of targeted therapeutics awaiting FDA approval on the rise

The success of these types of drugs has been noted by pharmaceutical firms who are adding them to their development portfolios.
Posted in Health Insurance, Healthcare, Medicare |

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.